Correlation Between Heron Therapeuti and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Heron Therapeuti and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heron Therapeuti and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Heron Therapeuti and Scopus Biopharma, you can compare the effects of market volatilities on Heron Therapeuti and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heron Therapeuti with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heron Therapeuti and Scopus Biopharma.
Diversification Opportunities for Heron Therapeuti and Scopus Biopharma
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Heron and Scopus is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Heron Therapeuti and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Heron Therapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heron Therapeuti are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Heron Therapeuti i.e., Heron Therapeuti and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Heron Therapeuti and Scopus Biopharma
If you would invest 160.00 in Heron Therapeuti on October 27, 2024 and sell it today you would earn a total of 23.00 from holding Heron Therapeuti or generate 14.37% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Heron Therapeuti vs. Scopus Biopharma
Performance |
Timeline |
Heron Therapeuti |
Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Heron Therapeuti and Scopus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Heron Therapeuti and Scopus Biopharma
The main advantage of trading using opposite Heron Therapeuti and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heron Therapeuti position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets |